Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.
about
NSAID therapy effects on healing of bone, tendon, and the enthesisFunctional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cellsProstaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.Mechanisms balancing skeletal matrix synthesis and degradation.Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology.Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair.Targeting rheumatoid inflammation and joint destruction in the mouse.Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.Immunohistochemical localization of key arachidonic acid metabolism enzymes during fracture healing in mice.Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy.The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation.Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.The protocol for the isolation and cryopreservation of osteoclast precursors from mouse bone marrow and spleen.Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null miceNew insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.Role of Epithelium Sodium Channel in Bone Formation.IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.Regulation of the prostaglandin pathway during development of invasive bladder cancer in miceAlteration of femoral bone morphology and density in COX-2-/- mice.Ectopic expression of cyclooxygenase-2-induced dedifferentiation in articular chondrocytes.Parecoxib and indomethacin delay early fracture healing: a study in rats.Pathophysiology of cyclooxygenase inhibition in animal models.A distinctive role of the leukotriene B4 receptor BLT1 in osteoclastic activity during bone loss.Reciprocal cross-talk between Prostaglandin E2 and bone in prostate cancer: a current review.Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis.Phosphatidylserine-containing liposomes: potential pharmacological interventions against inflammatory and immune diseases through the production of prostaglandin E(2) after uptake by myeloid derived phagocytes.Selective COX-2 Inhibitor (Meloxicam) and Tooth-Supporting Bone Quality. A Histomorphometric Study in Rats.Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.Effects of prostaglandin E2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells.Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism.Effect of compressive force on the production of prostaglandin E(2) and its receptors in osteoblastic Saos-2 cells.Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.Locally delivered salicylic acid from a poly(anhydride-ester): impact on diabetic bone regenerationBone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats.
P2860
Q27007096-D4B3AE23-CFEE-401F-B8B2-179A2836C0FEQ28236662-3968D42E-E76E-4566-B920-8418F75F971AQ33814310-B9F8B12A-9415-49A7-949E-3B491DAB8ED1Q33919462-69A2183E-5024-4212-9896-B6BCE7D83811Q34129759-C12AE154-133A-4A8E-9FD0-8010EE23CE9FQ34402915-C4C45A05-9D8B-4CDB-B18D-9C2769C36280Q34667102-4256A26F-BE39-4A78-85A5-FA7217C6244BQ34792085-A27DBF92-E0FB-42A2-B220-D40F57132C04Q34809811-0E16603E-3AE2-4B71-A572-5CC3E856F6D9Q34958651-D90BCA37-C414-40FE-8BE9-7EB2305F80F2Q35091768-43540002-BBAF-4CA6-A53E-B46F752804C7Q35188423-6785A736-2CBE-4C6B-9A1E-6A463E6D3478Q35233027-5AD2B99B-D55C-46A2-BF70-0F51BD96FBFAQ35246409-07DF5AB7-471D-4A29-8031-CDF12EF2B068Q36025402-AB565FF5-D946-4A0B-9E28-D18327F6903CQ36422055-6F3DAC8A-38F6-49D3-A6F8-2D2F61A6503DQ36426121-06051C53-81E2-424A-9AF4-8C37AF095F98Q36512269-058A04CA-B511-4F87-9E07-A76EE51ED796Q36648924-B7C16B10-C334-4C8F-96D9-C7455C2E4797Q36720098-15264836-CC0E-41AC-ABDA-77549F5882DEQ36836381-2AA3A097-28E9-4D5B-AF12-8C8285A0AD6CQ37041680-F88ECE60-391F-40C4-B63B-684A758A1D39Q37110168-26A1A3C1-7DED-4BB8-B2CB-DEC3CFF6D406Q37185014-13F55764-2DFB-482C-ADC4-9EA1220865B9Q37251966-E3AC964E-FD8E-4E25-8723-D8E2E21AB0F4Q37398476-A8D1B086-AE0A-4CA5-AE8F-DECE7B3E729FQ37482102-228DAD5B-3193-4C58-BE5D-136E03F45063Q37579078-34131BB1-10CB-4B7C-B9DE-AF452C60F8EDQ37627024-4EDFFDB6-0F8C-4167-9664-05C768E1388BQ37863538-9BAE4B1F-7E1A-4804-82E9-2EA26082AFDBQ38792812-DF87E06A-5F09-48EF-A715-6DFC1FE3465FQ39474660-36D36F5E-34A0-4C42-9806-E9A83FFA9D23Q39567498-86452C69-43BD-4EB6-A140-FC42BE090A8EQ39673628-7AEB63AF-71D7-42E3-B7A1-BF5754CB0D70Q40078096-6EB8630C-38F6-43D6-A087-BD8989A11DD1Q41449124-27C145E6-1AC2-474E-8836-A6A8DA64238CQ42577771-0B429B71-53BB-4159-9CC2-E43256A80B0EQ42671749-5C892E95-2D4B-4AC5-9B84-1B08025FD6ECQ43760469-3FA5EDEC-03E0-4425-B44D-0F30A8617CF7Q43781342-5D7D790D-99E9-469C-9479-8400E50544B2
P2860
Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@en
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@nl
type
label
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@en
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@nl
prefLabel
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@en
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@nl
P2093
P2860
P356
P1476
Prostaglandin G/H synthase-2 i ...... eoclast-like cells in culture.
@en
P2093
A M Freeman
C C Pilbeam
J A Lorenzo
S G Morham
P2860
P304
P356
10.1172/JCI8195
P407
P577
2000-03-01T00:00:00Z